The seminar will examine the current state of health care law and what the future might hold. This program will cover the broad range of issues confronting you and your clients today: Drug/Device Promotion and Advertising: Hot Topics; Marketing Activities and Provider Relationships: Rules and More, including False claims, anti-kickback, and Stark laws; Health Care Reform: A Year Later, including discussions on HIPAA and HITECH, ACOs, and Enforcement Tools; Compliance Investigation: Hypothetical Case.
For more information, please visit the PLI Web site.
Related Insights
23 October 2024
Health Care Law Today
Private Equity Investments in Oncology: Top Five Things to Know
Although private equity (PE) sponsors have been active investors in the health care services industry for the last decade, PE-backed health care providers today constitute only 4% of the United States health market by revenue.
23 October 2024
Health Care Law Today
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List
Less than a week after the FDA determined that the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been “resolved” and removed from the FDA’s shortage list, the Outsourcing Facilities Association filed a lawsuit against the FDA relating to the agency’s removal of tirzepatide, from the FDA’s drug shortage list.
23 October 2024
Foley Ignite
2024 Reflections and a Look Ahead to 2025: Examining Trends in M&A, Cross Border Financing, and AI
The mergers and acquisitions landscape in 2024 showed signs of recovery following the slump experienced in 2023.